Literature DB >> 23678125

Paraventricular hypothalamic regulation of trigeminovascular mechanisms involved in headaches.

Claude Robert1, Laurence Bourgeais, Charles-Daniel Arreto, Miguel Condes-Lara, Rodrigo Noseda, Thérèse Jay, Luis Villanueva.   

Abstract

While functional imaging and deep brain stimulation studies point to a pivotal role of the hypothalamus in the pathophysiology of migraine and trigeminal autonomic cephalalgias, the circuitry and the mechanisms underlying the modulation of medullary trigeminovascular (Sp5C) neurons have not been fully identified. We investigated the existence of a direct anatomo-functional relationship between hypothalamic excitability disturbances and modifications of the activities of Sp5C neurons in the rat. Anterograde and retrograde neuronal anatomical tracing, intrahypothalamic microinjections, extracellular single-unit recordings of Sp5C neurons, and behavioral trials were used in this study. We found that neurons of the paraventricular nucleus of the hypothalamus (PVN) send descending projections to the superior salivatory nucleus, a region that gives rise to parasympathetic outflow to cephalic and ocular/nasal structures. PVN cells project also to laminae I and outer II of the Sp5C. Microinjections of the GABAA agonist muscimol into PVN inhibit both basal and meningeal-evoked activities of Sp5C neurons. Such inhibitions were reduced in acutely restrained stressed rats. GABAA antagonist gabazine infusions into the PVN facilitate meningeal-evoked responses of Sp5C neurons. PVN injections of the neuropeptide pituitary adenylate cyclase activating peptide (PACAP38) enhance Sp5C basal activities, whereas the antagonist PACAP6-38 depresses all types of Sp5C activities. 5-HT1B/D receptor agonist naratriptan infusion confined to the PVN depresses both basal and meningeal-evoked Sp5C activities. Our findings suggest that paraventricular hypothalamic neurons directly control both spontaneous and evoked activities of Sp5C neurons and could act either as modulators or triggers of migraine and/or trigeminal autonomic cephalalgias by integrating nociceptive, autonomic, and stress processing mechanisms.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23678125      PMCID: PMC6618837          DOI: 10.1523/JNEUROSCI.0439-13.2013

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  41 in total

1.  Stereotactic stimulation of posterior hypothalamic gray matter in a patient with intractable cluster headache.

Authors:  M Leone; A Franzini; G Bussone
Journal:  N Engl J Med       Date:  2001-11-08       Impact factor: 91.245

2.  Mechanical response properties of A and C primary afferent neurons innervating the rat intracranial dura.

Authors:  Dan Levy; Andrew M Strassman
Journal:  J Neurophysiol       Date:  2002-12       Impact factor: 2.714

3.  Behavioral effects of local microinfusion of pituitary adenylate cyclase activating polypeptide (PACAP) into the paraventricular nucleus of the hypothalamus (PVN).

Authors:  Seth D Norrholm; Mahasweta Das; Gábor Légrádi
Journal:  Regul Pept       Date:  2005-05-15

4.  Properties of neurons in the trigeminal nucleus caudalis responding to noxious dural and facial stimulation.

Authors:  S Bolton; C T O'Shaughnessy; P J Goadsby
Journal:  Brain Res       Date:  2005-06-07       Impact factor: 3.252

5.  Functional magnetic resonance imaging in spontaneous attacks of SUNCT: short-lasting neuralgiform headache with conjunctival injection and tearing.

Authors:  A May; A Bahra; C Büchel; R Turner; P J Goadsby
Journal:  Ann Neurol       Date:  1999-11       Impact factor: 10.422

6.  Persistence of attacks of cluster headache after trigeminal nerve root section.

Authors:  Manjit S Matharu; Peter J Goadsby
Journal:  Brain       Date:  2002-05       Impact factor: 13.501

7.  Evidence that Fluoro-Gold can be transported avidly through fibers of passage.

Authors:  R J Dado; R Burstein; K D Cliffer; G J Giesler
Journal:  Brain Res       Date:  1990-11-19       Impact factor: 3.252

8.  Posterior hypothalamic and brainstem activation in hemicrania continua.

Authors:  Manjit S Matharu; Anna S Cohen; David J McGonigle; Nick Ward; Richard S Frackowiak; Peter J Goadsby
Journal:  Headache       Date:  2004-09       Impact factor: 5.887

9.  Posterior hypothalamic activation in paroxysmal hemicrania.

Authors:  Manjit S Matharu; Anna S Cohen; Richard S J Frackowiak; Peter J Goadsby
Journal:  Ann Neurol       Date:  2006-03       Impact factor: 10.422

10.  Acute stress-induced changes in hippocampal/prefrontal circuits in rats: effects of antidepressants.

Authors:  Cyril Rocher; Michael Spedding; Carmen Munoz; Thérèse M Jay
Journal:  Cereb Cortex       Date:  2004-02       Impact factor: 5.357

View more
  34 in total

Review 1.  Update on animal models of migraine.

Authors:  Marcela Romero-Reyes; Simon Akerman
Journal:  Curr Pain Headache Rep       Date:  2014-11

Review 2.  CGRP as a neuropeptide in migraine: lessons from mice.

Authors:  Andrew F Russo
Journal:  Br J Clin Pharmacol       Date:  2015-07-14       Impact factor: 4.335

Review 3.  Overview of Neuropeptides: Awakening the Senses?

Authors:  Andrew F Russo
Journal:  Headache       Date:  2017-05       Impact factor: 5.887

Review 4.  Serotonin, 5HT1 agonists, and migraine: new data, but old questions still not answered.

Authors:  Greg Dussor
Journal:  Curr Opin Support Palliat Care       Date:  2014-06       Impact factor: 2.302

Review 5.  Pathophysiology of Migraine: A Disorder of Sensory Processing.

Authors:  Peter J Goadsby; Philip R Holland; Margarida Martins-Oliveira; Jan Hoffmann; Christoph Schankin; Simon Akerman
Journal:  Physiol Rev       Date:  2017-04       Impact factor: 37.312

Review 6.  Recent Advances in Pharmacotherapy for Migraine Prevention: From Pathophysiology to New Drugs.

Authors:  Jonathan Jia Yuan Ong; Diana Yi-Ting Wei; Peter J Goadsby
Journal:  Drugs       Date:  2018-03       Impact factor: 9.546

Review 7.  CGRP and migraine: could PACAP play a role too?

Authors:  Eric A Kaiser; Andrew F Russo
Journal:  Neuropeptides       Date:  2013-10-23       Impact factor: 3.286

8.  Migraine pathophysiology: anatomy of the trigeminovascular pathway and associated neurological symptoms, CSD, sensitization and modulation of pain.

Authors:  Rodrigo Noseda; Rami Burstein
Journal:  Pain       Date:  2013-12       Impact factor: 6.961

Review 9.  Migraine and inhibitory system - I can't hold it!

Authors:  Caterina Mainero; Celine Louapre
Journal:  Curr Pain Headache Rep       Date:  2014-07

Review 10.  Sex and the migraine brain.

Authors:  D Borsook; N Erpelding; A Lebel; C Linnman; R Veggeberg; P E Grant; C Buettner; L Becerra; R Burstein
Journal:  Neurobiol Dis       Date:  2014-03-21       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.